• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
ALEXMED ePosters
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 7 (2025)
Volume Volume 6 (2024)
Volume Volume 5 (2023)
Volume Volume 4 (2022)
Volume Volume 3 (2021)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 2 (2020)
Volume Volume 1 (2019)
Rida, A. (2021). USE OF AUTOLOGOUS ADIPOSE TISSUE DERIVED STEM CELLS FOR TREATMENT OF KNEE OSTEOARTHRITIS: ACLINICAL STUDY. ALEXMED ePosters, 3(2), 20-21. doi: 10.21608/alexpo.2021.67896.1136
Ahmed Hossam Eldin Rida. "USE OF AUTOLOGOUS ADIPOSE TISSUE DERIVED STEM CELLS FOR TREATMENT OF KNEE OSTEOARTHRITIS: ACLINICAL STUDY". ALEXMED ePosters, 3, 2, 2021, 20-21. doi: 10.21608/alexpo.2021.67896.1136
Rida, A. (2021). 'USE OF AUTOLOGOUS ADIPOSE TISSUE DERIVED STEM CELLS FOR TREATMENT OF KNEE OSTEOARTHRITIS: ACLINICAL STUDY', ALEXMED ePosters, 3(2), pp. 20-21. doi: 10.21608/alexpo.2021.67896.1136
Rida, A. USE OF AUTOLOGOUS ADIPOSE TISSUE DERIVED STEM CELLS FOR TREATMENT OF KNEE OSTEOARTHRITIS: ACLINICAL STUDY. ALEXMED ePosters, 2021; 3(2): 20-21. doi: 10.21608/alexpo.2021.67896.1136

USE OF AUTOLOGOUS ADIPOSE TISSUE DERIVED STEM CELLS FOR TREATMENT OF KNEE OSTEOARTHRITIS: ACLINICAL STUDY

Article 89, Volume 3, Issue 2, June 2021, Page 20-21  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2021.67896.1136
View on SCiNiTO View on SCiNiTO
Author
Ahmed Hossam Eldin Rida email
Department of Orthopaedic Surgery and Traumatology, Faculty of Medicine, University of Alexandria.
Abstract
Degenerative Osteoarthritis (OA) is considered to be the most prevalent form of arthritis and one of the main causes of disability. It is a condition that affects the joints causing pain, stiffness and difficulty in performing daily activities. The most commonly affected joint is the knee
There is no cure for OA and most treatments aim to manage patients’ symptoms. All these forms of treatments are palliative and only provide pain relief, failing to prevent cartilage damage and further destruction of other joint tissues. Joint replacement is the only currently available treatment able to provide pain relief and satisfactory function recovery, when the final stages of OA are reached.
The regenerative medicine field is developing and showing promising results aiming to stop and revert the degeneration associated with OA. Injection of adipose tissue derived mesenchymal stem cell (MSC) intraarticularly is one of these methods.
AIM OF THE WORK
The aim of this study was to evaluate the efficacy of intra-articular injection of adipose tissue derived mesenchymal stem cells (ADMSC) in the treatment of mild to moderate degenerative knee osteoarthritis.
Keywords
Degenerative Osteoarthritis; no cure for OA; Adipose Tissue Derived Stem Cells
Supplementary Files
download 0020 Presentation9 (2).pdf
Statistics
Article View: 185
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.